Clinical Trials Browser

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07432178 2026-02-25

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

Phase 3 Not yet recruiting

2,288 enrolled

Breast

Breast Neoplasms

NCT07418060 2026-02-24

PREHAB KINELGD

Phase NA Not yet recruiting

72 enrolled

Breast

Breast Neoplasms

NCT07425379 2026-02-24

Prehabilitation in Breast Cancer Surgery

Phase NA Not yet recruiting

54 enrolled

Breast

Breast Neoplasms

NCT07427407 2026-02-24

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

Not yet recruiting

100 enrolled

Breast

Breast Neoplasms

NCT07429487 2026-02-24

WATCH AND ACT

Phase NA Not yet recruiting

98 enrolled

BreastGastrointestinal

Breast Neoplasms, Fatigue, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07425548 2026-02-23

JOUVENCE

Phase NA Not yet recruiting

22 enrolled

Breast

Breast Neoplasms

NCT07426913 2026-02-23

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Phase NA Not yet recruiting

30 enrolled

Breast

Breast Neoplasms

NCT06958224 2026-02-20

ESCAT

Phase NA Not yet recruiting

360 enrolled

BreastGastrointestinal

Breast Neoplasms, Liver Neoplasms

NCT07394946 2026-02-20

NELOPHER

Phase 2 Not yet recruiting

126 enrolled

Breast

Breast Neoplasms

NCT07423611 2026-02-20

RACE

Phase 2 Not yet recruiting

388 enrolled

Breast

Breast Neoplasms

NCT07197684 2026-02-19

Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery

Phase NA Not yet recruiting

120 enrolled

Breast

Breast Neoplasms, Pain, Postoperative, Chronic Pain

NCT07419711 2026-02-19

Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity

Phase NA Not yet recruiting

120 enrolled

Breast

Breast Neoplasms

NCT07419867 2026-02-19

A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

Phase 2 Not yet recruiting

300 enrolled

Breast

Breast Neoplasms

NCT07319195 2026-02-18

WINIT-BC

Phase EARLY_PHASE1 Not yet recruiting

32 enrolled

Breast

Breast Neoplasms

NCT07410559 2026-02-18

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

Phase 2 Not yet recruiting

189 enrolled

Breast

Breast Neoplasms

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

Phase 2 Not yet recruiting

68 enrolled

Breast

Breast Neoplasms

Clinical Trials

CBD for Breast Cancer Primary Tumors

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

IMPOWER-QoL: IMPact Of Discontinuing Premedication for WEekly Paclitaxel on bReast Cancer Patient's Quality Of Life

Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy

preEMBER

STEPS-BC

E-C-HAU

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

A Pilot Study to Evaluate the Effectiveness of Focused Massage on Pain, Mobility, and Quality of Life During Radiation Treatment for Patients With Breast Cancer

Serplulimab Combined With Trastuzumab Rezetecan as Neoadjuvant Therapy for Triple-Negative Breast Cancer

PREACT

Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile

KompXX

GRADE

The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors

YL202 Versus Treatment of Physician's Choice in Patients With HR+/HER2- Breast Cancer

LUBRECA

Behavioral Pain Intervention for Older Cancer Patients

Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

VIOLET

TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer

BREATH-RCT

P-RAD(+)TN-DCT

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast Cancer

A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

AdheRA

DETOXp

SGLT2i/DPPi

QVA-Mod

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）

PREHAB KINELGD

Prehabilitation in Breast Cancer Surgery

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

WATCH AND ACT

JOUVENCE

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

ESCAT

NELOPHER

RACE

Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery

Grape Polyphenols for Prevention of Chemotherapy-Induced Cardiotoxicity

A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

WINIT-BC

Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer